Hesperidin inhibits NOX4 mediated oxidative stress and inflammation by upregulating SIRT1 in experimental diabetic neuropathy
NOX4
Diabetic Neuropathy
DOI:
10.1016/j.exger.2022.112064
Publication Date:
2022-12-15T01:08:29Z
AUTHORS (4)
ABSTRACT
Hesperidin possesses myriads of pharmacological benefits, including anti-inflammatory and antioxidant properties. Herein, we speculated that the described benefits hesperidin might be due to its potentiating action on SIRT1; thereby, inhibition NOX4. We developed diabetic neuropathy in Sprague-Dawley rats by feeding them a high-fat diet (HFD) for 12 weeks. checked effect level oxidative stress, inflammatory markers, NOX4, SIRT1 biochemical analysis, histopathology, immunoblotting, immunocytochemistry, real-time qPCR HFD-fed Palmitate encountered rat glial C6 cells. administration improved mechanical, thermal allodynia, glucose homeostasis. There was decrease stress inflammation an enhanced enzymes. Besides, expression NOX4 down-regulated, while upregulated. Interestingly, treatment protected from damage upregulating inhibiting expression.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....